BD Executive and Leadership Team

Tom Polen, the Chairman, Chief Executive Officer & President at BD, directs the overarching corporate strategy and long-term vision for the global medical technology enterprise. Polen oversees the integration of medical device manufacturing with advanced diagnostic systems to ensure consistent growth across international markets. By aligning the executive leadership team with the core mission of improving patient safety and drug delivery, the Chairman, Chief Executive Officer & President maintains a focus on operational excellence and market expansion. Tom Polen drives the development of healthcare solutions that support hospitals and laboratories worldwide. Through rigorous oversight of the company's diverse portfolio, the executive ensures that innovation remains central to the business model. This leadership role involves constant engagement with the Board to refine corporate governance and sustain competitive advantages in the complex medical technology landscape, ultimately securing the company's position as a leader in global health.

Vitor Roque, the Executive VP & Chief Financial Officer at BD, manages the financial health and capital allocation strategies for the global medical technology organization. Roque oversees fiscal planning, investor relations, and the financial reporting required to support the company's extensive manufacturing and diagnostic operations. By driving cost-efficiency initiatives across the supply chain, the Executive VP & Chief Financial Officer ensures that resources are directed toward high-growth areas like biosciences and patient safety solutions. Vitor Roque monitors global market trends to mitigate financial risks and optimize revenue streams. This leadership role involves working with the Board to maintain a strong balance sheet and fund long-term innovation projects. Through disciplined financial management, the Executive VP & Chief Financial Officer supports the company's ability to scale operations and deliver value to shareholders. Roque maintains a focus on sustainable growth, ensuring that the financial foundation remains stable while the company expands its footprint in international healthcare markets.

Bridget Bagnato, the President, Worldwide, Specimen Management at BD, directs the global operations and strategic growth for the specimen management business unit. Bagnato oversees the development and manufacturing of laboratory equipment designed to improve the accuracy and efficiency of diagnostic testing. By driving the expansion of specimen management solutions into new international markets, the President, Worldwide, Specimen Management ensures that laboratories have the tools necessary to deliver reliable results to healthcare providers. Bridget Bagnato manages the cross-functional teams responsible for product lifecycle and customer support within this critical segment. This leadership role involves coordinating with other business units to integrate specimen management technologies into the broader diagnostic systems portfolio. Through the optimization of supply chain and product performance, the President, Worldwide, Specimen Management supports the company's commitment to patient safety and diagnostic excellence. Bagnato maintains a focus on operational scale, ensuring that the business unit meets the high-volume demands of modern clinical laboratories.

Sandra Ostler, the Chief Information Officer at BD, manages the digital infrastructure and data systems that support the company's global manufacturing and diagnostic operations. Ostler architects secure, scalable technology frameworks to enhance the efficiency of laboratory equipment and healthcare solutions. By overseeing the digital transformation of internal processes, the Chief Information Officer ensures that data-driven insights inform decision-making across all business units. Sandra Ostler drives the implementation of advanced cybersecurity protocols to protect sensitive patient and laboratory information. This role involves close collaboration with other C-suite leaders to integrate information technology with product development cycles. Through the modernization of enterprise systems, the Chief Information Officer supports the company's ability to deliver high-quality medical devices to healthcare providers. Ostler maintains a focus on operational agility, ensuring that the technological backbone of the organization remains robust enough to handle the demands of a rapidly evolving global medical market.

Erik Herazo, the Chief Technology Officer at BD, leads the research and development initiatives focused on next-generation diagnostic systems and laboratory equipment. Herazo directs the engineering teams responsible for creating innovative medical devices that enhance patient safety and drug delivery accuracy. By overseeing the technical roadmap, the Chief Technology Officer ensures that the company remains at the forefront of bioscience advancements. Erik Herazo drives the integration of new technologies into existing product lines to improve healthcare provider workflows. This leadership role involves managing complex R&D pipelines and fostering partnerships with academic and clinical institutions to accelerate product innovation. Through the application of cutting-edge scientific research, the Chief Technology Officer supports the company's mission to solve critical healthcare challenges. Herazo maintains a focus on technical excellence, ensuring that every product developed meets the highest standards of quality and reliability required by hospitals and laboratories across the globe.

Jillian Streeter, the Manager, Quality & Chief Marketing Officer, Instrument at BD, directs the quality assurance protocols and marketing strategies specifically for the company's instrument and diagnostic hardware portfolio. Streeter oversees the alignment of product quality standards with market demands to ensure that laboratory equipment meets the rigorous requirements of healthcare providers. By driving brand positioning for diagnostic systems, the Manager, Quality & Chief Marketing Officer, Instrument ensures that the value proposition of these tools is clearly communicated to clinical customers. Jillian Streeter manages the intersection of regulatory compliance and commercial growth, ensuring that every instrument launch adheres to safety standards while capturing market share. This role involves coordinating with product development teams to refine features based on user feedback. Through the integration of quality control and marketing, the Manager, Quality & Chief Marketing Officer, Instrument supports the company's reputation for reliability and innovation in the medical technology sector.

Devon Peterson, the Director and Chief of Staff To Chief Revenue Officer at BD, coordinates the strategic initiatives and operational workflows within the global revenue organization. Peterson oversees the execution of sales strategies and ensures that the revenue team remains aligned with the company's broader goals in medical technology and diagnostic systems. By facilitating communication between the Chief Revenue Officer and regional sales leaders, the Director and Chief of Staff To Chief Revenue Officer drives efficiency in the commercial pipeline. Devon Peterson manages the administrative and operational processes that support the expansion of drug delivery and bioscience product sales. This role involves analyzing revenue data to identify growth opportunities and optimizing the sales force's engagement with hospitals and healthcare providers. Through the management of key strategic projects, the Director and Chief of Staff To Chief Revenue Officer supports the company's ability to meet aggressive financial targets and maintain a strong market presence.

Denise Fleming, the Executive VP & Chief Information Officer at BD, leads the global digital strategy and enterprise-wide information systems. Fleming oversees the deployment of advanced analytics and cloud infrastructure to support the company's manufacturing and diagnostic service delivery. By driving the adoption of digital tools that enhance operational transparency, the Executive VP & Chief Information Officer ensures that the organization can respond quickly to the needs of hospitals and laboratories. Denise Fleming manages the integration of complex data sets to improve the efficiency of drug delivery and bioscience research. This leadership role involves collaborating with other executives to ensure that technology investments directly contribute to the company's mission of advancing health. Through the implementation of robust digital platforms, the Executive VP & Chief Information Officer supports the company's global scale and operational resilience. Fleming maintains a focus on innovation, ensuring that the technological infrastructure remains a competitive asset in the medical technology industry.

Meera Gopalakrishnan, the Senior Vice President and Global Chief Marketing Officer at BD, directs the worldwide marketing strategy and brand development for the company's entire medical technology portfolio. Gopalakrishnan oversees the creation of campaigns that highlight the impact of diagnostic systems, laboratory equipment, and healthcare solutions on patient outcomes. By driving market research and customer insights, the Senior Vice President and Global Chief Marketing Officer ensures that the company's innovations resonate with healthcare providers and laboratory professionals. Meera Gopalakrishnan manages the global marketing team to maintain a consistent brand identity across diverse international regions. This leadership role involves working with product managers to launch new solutions that address critical gaps in patient safety and drug delivery. Through the execution of comprehensive marketing strategies, the Senior Vice President and Global Chief Marketing Officer supports the company's growth and strengthens its position as a trusted partner in the global healthcare ecosystem.

John DeFord, the Executive Vice President & Chief Technology Officer at BD, leads the long-term technology vision and the development of breakthrough medical devices. DeFord oversees the scientific research and engineering teams that focus on creating advanced diagnostic systems and laboratory equipment. By driving the innovation pipeline, the Executive Vice President & Chief Technology Officer ensures that the company continues to provide cutting-edge solutions for drug delivery and biosciences. John DeFord manages the intellectual property portfolio and fosters collaborations with external innovators to expand the company's technological capabilities. This leadership role involves setting the strategic direction for R&D to ensure that new products meet the evolving needs of hospitals and healthcare providers. Through the application of advanced engineering principles, the Executive Vice President & Chief Technology Officer supports the company's mission to improve patient safety. DeFord maintains a focus on technical leadership, ensuring that the organization remains a pioneer in the medical technology field.